AkzoNobel and Evonik announce production joint venture for chlorine/potassium hydroxide solution
The 50-50 joint venture involves the construction and operation of a dedicated plant at AkzoNobel's existing site in Ibbenbüren. It will have an annual nameplate capacity of around 130,000 metric tons of potassium hydroxide solution and 82,000 metric tons of chlorine. This will strengthen the leading market positions of both companies. Financial details were not disclosed.
AkzoNobel will take over commercialization of chlorine and hydrogen at the new plant, and will process these products directly at the Ibbenbüren site. Evonik will take over the potassium hydroxide solution for commercialization and processing at its own site in Lülsdorf. This is where Evonik processes potassium hydroxide solution into potassium carbonate (potash).
All production of chlorine, potassium hydroxide and caustic lye using mercury-based amalgam electrolysis has to stop by the end of 2017 due to legislative requirements. The planned new membrane electrolysis plant will use a sustainable process which has a more positive environmental profile.
The joint venture is subject to approval from the applicable regulatory authorities.
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.